मैगज़्टर गोल्ड के साथ असीमित हो जाओ

मैगज़्टर गोल्ड के साथ असीमित हो जाओ

10,000 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ

$149.99
 
$74.99/वर्ष
The Perfect Holiday Gift Gift Now

Odisha's pharma pitch

Express Pharma

|

January 2026

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

Odisha's pharma pitch

The recently held Odisha Pharma Summit 2025, the state's first dedicated summit focused on pharmaceuticals, medical devices, and life sciences manufacturing, is by all accounts a success. (https://www.expresspharma.in/odisha-pharma-summit-2025-positions-odisha-as-eastern-indias-emerging-life-sciences-hub-odisha-cm/)

The December 16 summit reportedly attracted strong investor response, with a total of 69 Memoranda of Understanding (MoUs) signed across pharmaceuticals, medical technologies, and industrial infrastructure. These MoUs represent an investment commitment of Rs 7,043 crore, with an estimated employment generation potential of 44,646 jobs.

Pharmaceuticals bagged the lion's share (32 MoUs with proposed investments of Rs 2,681 crore, generating over 6,528 employment opportunities) followed by Medical Technology & Devices (12 MoUs, Rs 582 crore in committed investments, to create over 1,878 jobs). An MoU was also signed to set up an industrial park, with an investment of Rs 3,000 crore, expected to generate nearly 30,000 jobs.

The Odisha government's pharma foray is part of the government's overall Viksit Bharat @2047 vision, and specifically to boost investment and development of Eastern India under the Purvodaya (look east) policy push.

The state has charted its own policy, Samruddha Odisha 2036, for becoming a developed, future-ready state by 2036, Odisha's centenary year of statehood.

Summing up the intent, Hon'ble Chief Minister Shri Mohan Charan Majhi while addressing the Odisha Pharma Summit 2025 on December 16, 2025 said, “Odisha will be a leading destination for pharmaceutical and medical-device investments – the most competitive hub for innovation and jobs. Yahi samay hai.”

But will Odisha catch up with more established pharma/medtech hubs in the country? After all, what does the “new kid on the block” offer to attract investments?

PLI plus policy

Express Pharma से और कहानियाँ

Express Pharma

Express Pharma

Speed and flexibility play a critical role in how we compete with larger global players

Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Vizag rising: Shaping India's pharma future

At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth

time to read

9 mins

January 2026

Express Pharma

Express Pharma

Future of pharma: Trends, challenges & AI

Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies

time to read

2 mins

January 2026

Express Pharma

Express Pharma

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments

When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.

time to read

1 mins

January 2026

Express Pharma

Express Pharma

Can Indian biosimilars and generics restate accessibility in global underserved markets?

Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare

time to read

3 mins

January 2026

Express Pharma

Express Pharma

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Results win customers. Leadership discipline keeps them

Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.

time to read

3 mins

January 2026

Express Pharma

Express Pharma

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF

India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge

time to read

8 mins

January 2026

Express Pharma

Express Pharma

PRUV® -The original Sodium Stearyl Fumarate

JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago

time to read

5 mins

January 2026

Express Pharma

Express Pharma

Odisha's pharma pitch

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

time to read

5 mins

January 2026

Listen

Translate

Share

-
+

Change font size